Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.920
+0.020 (1.05%)
At close: Feb 6, 2026
Kangmei Pharmaceutical Revenue
Kangmei Pharmaceutical had revenue of 1.38B CNY in the quarter ending September 30, 2025, a decrease of -1.22%. This brings the company's revenue in the last twelve months to 5.28B, up 1.18% year-over-year. In the year 2024, Kangmei Pharmaceutical had annual revenue of 5.19B with 6.47% growth.
Revenue (ttm)
5.28B
Revenue Growth
+1.18%
P/S Ratio
5.03
Revenue / Employee
1.25M
Employees
4,233
Market Cap
26.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.19B | 315.12M | 6.47% |
| Dec 31, 2023 | 4.87B | 693.87M | 16.60% |
| Dec 31, 2022 | 4.18B | 27.63M | 0.67% |
| Dec 31, 2021 | 4.15B | -1.26B | -23.27% |
| Dec 31, 2020 | 5.41B | -6.03B | -52.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition